Next-Generation Targeted Therapies in Non-Small Cell Lung Cancer

0 Views
administrator
administrator
07/14/23

In this segment, panelists discuss the number of early-phase clinical trials that have demonstrated impressive efficacy for next-generation ALK and EGFR inhibitors for patients with non-small cell lung cancer.

To view more from this discussion, visit http://www.onclive.com/peer-ex....change/nsclc-outcome

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next